SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from METLIFE (MET) — Nov 21, 2012

METLIFE INC
Date: Nov. 21, 2012 · CIK: 0001099219 · Accession: 0001193125-12-478495

AI Filing Summary & Sentiment

File numbers found in text: 001-15787

Date
November 21, 2012
Author
/s/ Peter M. Carlson
Form
CORRESP
Company
METLIFE INC

Letter

Division of Corporation Finance United States Securities and Exchange Commission Filed February 28, 2012 Form 10-Q for the Quarterly Period Ended March 31, 2012 Filed May 8, 2012 File Number: 001-15787

Dear Mr. Rosenberg:

This letter sets forth the Company’s response to related follow-up comments as clarified by further discussions with the Commission on November 19, 2012.

Form 10-K for the Year Ended December 31, 2011

Item 8. Financial Statements and Supplementary Data

Notes to the Consolidated Financial Statements

18. Equity

Statutory Equity and Income, page 40

1. In the course of your review of the requirements under ASC 944-505-50-1(b), you have requested additional disclosures regarding the amount of statutory capital and surplus necessary to satisfy regulatory requirements if significant in relation to statutory capital and surplus. Specifically, during our telephone call on November 19, 2012 you asked us to provide proposed enhanced financial statement disclosures, to be included in Form 10-K for the year ending December 31, 2012, that include additional quantitative information with respect to foreign subsidiaries.

Mr. James B. Rosenberg

Securities and Exchange Commission

November 21, 2012

Page

Management Response:

Commencing with the Company’s Form 10-K for the year ending December 31, 2012, we will include the following under “Statutory Equity and Income” currently in Note 18 to the 2011 Form 10-K (changes from Response 1.C. in our letter to you dated September 25, 2012 are underlined):

Each U.S. insurance company’s state of domicile imposes risk-based capital (“RBC”) requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). American Life does not write business in Delaware or any other domestic state and, as such, is exempt from RBC requirements by Delaware law. Regulatory compliance is determined by a ratio of a company’s total adjusted capital, calculated in the manner prescribed by the NAIC (“TAC”) to its authorized control level RBC, calculated in the manner prescribed by the NAIC (“ACL RBC”). Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC (“Corrective Action RBC”). While not required by or filed with insurance regulators, the Company also calculates a combined RBC ratio (“Combined RBC Ratio”), which is determined by dividing the sum of TAC for the Company’s principal U.S. insurance subsidiaries, excluding American Life, by the sum of Corrective Action RBC for such subsidiaries. The Company’s Combined RBC Ratio was in excess of XXX% for all periods presented. In addition, all non-exempted U.S. insurance subsidiaries individually exceeded Corrective Action RBC for all periods presented.

The Company’s foreign operations are regulated by applicable authorities of the countries in which each entity operates and are subject to minimum capital and solvency requirements in those countries before corrective action commences. As of December 31, 2012 and 2011, the adjusted capital of American Life’s insurance subsidiary in Japan, the Company’s largest foreign operation, was in excess of X times of the amount of capital that would require corrective action. Excluding Japan, the aggregate required capital and surplus of the Company’s other foreign insurance operations was $X.X billion and the aggregate actual regulatory capital and surplus of such operations was $X.X billion as of date of the most recent required capital adequacy calculation for each jurisdiction. Each of those other foreign insurance operations exceeded minimum capital and solvency requirements of their respective countries for all periods presented.

*****

We acknowledge that:

•

The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

•

Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

•

The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Mr. James B. Rosenberg

Securities and Exchange Commission

November 21, 2012

Page

If we may be of assistance in answering any questions that may arise in connection with the staff’s review of our response letter, please call me at 212-578-2005. For your convenience, we are sending a copy of this letter to you via e-mail at RosenbergJ@SEC.GOV, in addition to filing it on EDGAR under the form type label CORRESP.

Sincerely,
/s/ Peter M. Carlson

Show Raw Text
CORRESP
1
filename1.htm

Correspondence

 Peter M. Carlson

Executive Vice President and

Chief Accounting Officer

pcarlson@metlife.com

 November 21, 2012

 Mr. James B. Rosenberg

 Senior Assistant Chief Accountant

Division of Corporation Finance

 United States
Securities and Exchange Commission

 100 F Street, N.E.

 Washington, D.C. 20549

Re:
MetLife, Inc.

Form 10-K for the Fiscal Year Ended December 31, 2011

Filed February 28, 2012

Form 10-Q for the Quarterly Period Ended March 31, 2012

Filed May 8, 2012

File Number: 001-15787

 Dear
Mr. Rosenberg:

 This letter sets forth the Company’s response to related follow-up comments as clarified by further discussions with
the Commission on November 19, 2012.

 Form 10-K for the Year Ended December 31, 2011

Item 8. Financial Statements and Supplementary Data

 Notes to the Consolidated Financial Statements

 18. Equity

 Statutory Equity and Income, page 40

 1. In the course of your review of the requirements under ASC 944-505-50-1(b), you have requested additional disclosures regarding the amount of statutory capital and surplus necessary to satisfy
regulatory requirements if significant in relation to statutory capital and surplus. Specifically, during our telephone call on November 19, 2012 you asked us to provide proposed enhanced financial statement disclosures, to be included in Form 10-K
for the year ending December 31, 2012, that include additional quantitative information with respect to foreign subsidiaries.

 Mr. James B. Rosenberg

 Securities and Exchange Commission

 November 21, 2012

 Page
 2

 Management Response:

 Commencing with the Company’s Form 10-K for the year ending December 31, 2012, we will include the following under “Statutory Equity and Income” currently in Note 18 to the 2011 Form
10-K (changes from Response 1.C. in our letter to you dated September 25, 2012 are underlined):

 Each U.S. insurance
company’s state of domicile imposes risk-based capital (“RBC”) requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). American Life does not write business in Delaware or any other
domestic state and, as such, is exempt from RBC requirements by Delaware law. Regulatory compliance is determined by a ratio of a company’s total adjusted capital, calculated in the manner prescribed by the NAIC (“TAC”) to its
authorized control level RBC, calculated in the manner prescribed by the NAIC (“ACL RBC”). Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. The
minimum level of TAC before corrective action commences is twice ACL RBC (“Corrective Action RBC”). While not required by or filed with insurance regulators, the Company also calculates a combined RBC ratio (“Combined RBC
Ratio”), which is determined by dividing the sum of TAC for the Company’s principal U.S. insurance subsidiaries, excluding American Life, by the sum of Corrective Action RBC for such subsidiaries. The Company’s Combined RBC Ratio was
in excess of XXX% for all periods presented. In addition, all non-exempted U.S. insurance subsidiaries individually exceeded Corrective Action RBC for all periods presented.

 The Company’s foreign operations are regulated by applicable authorities of the countries in which each entity operates and are subject to minimum capital and solvency requirements in those
countries before corrective action commences. As of December 31, 2012 and 2011, the adjusted capital of American Life’s insurance subsidiary in Japan, the Company’s largest foreign operation, was in excess of X times of the amount of
capital that would require corrective action. Excluding Japan, the aggregate required capital and surplus of the Company’s other foreign insurance operations was $X.X billion and the aggregate actual regulatory capital and surplus of such
operations was $X.X billion as of date of the most recent required capital adequacy calculation for each jurisdiction. Each of those other foreign insurance operations exceeded minimum capital and solvency requirements of their respective
countries for all periods presented.

 *****

 We acknowledge that:

•

 The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

•

 Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the
filing; and

•

 The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of
the United States.

 Mr. James B. Rosenberg

 Securities and Exchange Commission

 November 21, 2012

 Page
 3

 If we may be of assistance in answering any questions that may arise in connection with the staff’s
review of our response letter, please call me at 212-578-2005. For your convenience, we are sending a copy of this letter to you via e-mail at RosenbergJ@SEC.GOV, in addition to filing it on EDGAR under the form type label CORRESP.

Sincerely,

 /s/ Peter M. Carlson

Peter M. Carlson

cc:
Steven A. Kandarian

John C. R. Hele